Ginkgo Bioworks Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 11.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 754.88M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engi...